Sort
34,240 grants matching “atherosclerosis”
Shear Stress and Endothelial Pathophysiology in Intracranial Atherosclerosis
$581,146David Sigmund Liebeskind · University Of California Los Angeles · R01 · FY2024 · NS
Endothelial Dysfunction Due to HIV-1 Protease Inhibitors
$581,124Indiana Univ-Purdue Univ At Indianapolis · R01 · FY2003 · HL
Sleep, Circadian Rhythms, and Mechanisms of Cognitive Decline in the Human Brain
$581,117Andrew Lim · Sunnybrook Research Institute · R01 · FY2017 · AG
Arterial Stiffness and Brain Health in African Americans
$581,069Michelle Meyer · Univ Of North Carolina Chapel Hill · R01 · FY2020 · AG
Anti-inflammatory nanoparticle formulations to treat atherosclerosis
$580,993Willem Mulder · Icahn School Of Medicine At Mount Sinai · R01 · FY2015 · HL
Artery biomechanics and vascular damage in sickle cell disease
$580,863Manu O Platt · Georgia Institute Of Technology · R01 · FY2021 · HL
Artery biomechanics and vascular damage in sickle cell disease
$580,863Edward A Botchwey · Georgia Institute Of Technology · R01 · FY2022 · HL
DNA Methylation as a Biomarker of Exposure and Effect for Particles and Metals
$580,859Joel D Schwartz · Harvard School Of Public Health · R01 · FY2014 · ES
A nanoparticle-based vaccine targeting PCSK9
$580,797Bryce C Chackerian · University Of New Mexico Health Scis Ctr · R01 · FY2019 · HL
Understanding cellular architecture of the neurovascular unit and its function in the whole mouse brain
$580,763Yongsoo Kim · Pennsylvania State Univ Hershey Med Ctr · R01 · FY2021 · NS
CHARGE consortium: omics discovery for CVD and aging phenotypes
$580,749Bruce M Psaty · University Of Washington · R01 · FY2024 · HL
Cardiovascular Risk and Insulin Resistance: Age 7-40
$580,680Julia Steinberger · University Of Minnesota · R01 · FY2011 · DK
ERRgamma Agonists to Treat Muscular Dystrophy
$580,666Thomas P Burris · Saint Louis University · R01 · FY2016 · AR
ERRgamma Agonists to Treat Muscular Dystrophy
$580,666Thomas P Burris · Saint Louis University · R01 · FY2017 · AR
A Novel Approach to Examine Within-Class Therapeutic Exchangeability of Medications
$580,634Tobias Gerhard · Rutgers Biomedical And Health Sciences · R01 · FY2023 · AG
High Density Lipoprotein Biogenesis and Speciation
$580,616Henry J. Pownall · Methodist Hospital Research Institute · R01 · FY2017 · HL
High Density Lipoprotein Biogenesis and Speciation
$580,616Henry J. Pownall · Methodist Hospital Research Institute · R01 · FY2019 · HL
MMP-9 AS A PROINFLAMMATORY REGULATOR IN ATHEROGENESIS
$580,593Elaine Raines · University Of Washington · R01 · FY2010 · HL
Task Area A shall encompass annual follow-up of cohort members, clinical events investigations, study operations, and data analysis and manuscript writing. If implemented, Task A.1 will provide fundin
$580,527Wendy Post · Johns Hopkins University · N01 · FY2020 · HL
Systems genetics approaches to bile acid metabolisms
$580,506Karen Reue · University Of California Los Angeles · P01 · FY2017 · HL
Systems genetics approaches to bile acid metabolisms
$580,506Karen Reue · University Of California Los Angeles · P01 · FY2019 · HL
Accelerated CV Aging in Youth Related to CV Risk Factor Clusters
$580,497Elaine Mott Urbina · Cincinnati Childrens Hosp Med Ctr · R01 · FY2012 · HL
Social determinants of fatty liver disease and its racial/ethnic disparities: The Multi-Ethnic Study of Atherosclerosis
$580,398Mariana Lazo Elizondo · Drexel University · R01 · FY2025 · DK
Sensing Vulnerable Plaque in vivo by an All-optical Intravascular Ultrasound and Photoacoustic Catheter
$580,378Ji-Xin Cheng · Boston University (Charles River Campus) · R01 · FY2022 · HL
Genetic Architecture of Adiposity in Multiple Large Cohorts
$580,374Ingrid Bernadette Borecki · Washington University · R01 · FY2012 · DK